DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luukkanen, L.
Right arrow Articles by Elovaara, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luukkanen, L.
Right arrow Articles by Elovaara, E.

Vol. 29, Issue 8, 1096-1101, August 2001

Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue

Leena Luukkanen,1 Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen, and Eivor Elovaara

Laboratory of Toxicokinetics and Metabolism, Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland (L.L., J.M., E.E.); Viikki Drug Discovery Technology Center, Department of Pharmacy, University of Helsinki, Finland (L.L., T.F., J.T.); and Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland (P.T.)

Human UDP-glucuronosyltransferases (UGT, EC 2.4.1.17) involved in the biotransformation of pyrene were investigated by a sensitive fluorometric high-performance liquid chromatography (HPLC)method developed for determining activities toward 1-hydroxypyrene. The endpoint metabolite of pyrene, 1-pyrenylglucuronide, is a well-known urinary biomarker for the assessment of human exposure to polycyclic aromatic hydrocarbons. 1-Pyrenylglucuronide was synthesized using rat liver microsomes as biocatalyst. The yield was satisfactory, 22%. 1-Pyrenylglucuronide, identified by 1H NMR and by electrospray mass spectrometry, was used for method validation and calibration. The HPLC assay was very sensitive with a quantitation limit of 3 pg (8 fmol) for 1-pyrenylglucuronide. The assay was precise, showing a relative standard deviation of 5% or less at 0.1 to 300 µM 1-hydroxypyrene. Only 2 µg of microsomal protein was required for the assay in human liver. The glucuronidation of 1-hydroxypyrene was catalyzed at high rates in microsomes from pooled or three individual liver samples, showing comparable apparent Km values. The formation of 1-pyrenylglucuronide was catalyzed by recombinant human UGT1A6, UGT1A7, and UGT1A9, the Km values being 45, 12, and 1 µM, respectively. The apparent Km values in human liver microsomes, ranging from 6.9 to 8.6 µM, agreed well with these results. The method provides a sensitive tool for measuring extremely low UGT activities and a specific means for assessing interindividual differences in 1-hydroxypyrene-metabolizing UGT activities in human liver and other tissues.


1 Present address: Viikki Drug Discovery Technology Center, Department of Pharmacy, P.O. Box 56 (Viikinkaari 5E), FIN-00014 University of Helsinki, Finland.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
B. J. Dean, S. Chang, M. V. S. Elipe, Y.-Q. Xia, M. Braun, E. Soli, Y. Zhao, R. B. Franklin, and B. Karanam
Metabolism of MK-0524, a Prostaglandin D2 Receptor 1 Antagonist, in Microsomes and Hepatocytes from Preclinical Species and Humans
Drug Metab. Dispos., February 1, 2007; 35(2): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. Luukkanen, J. Taskinen, M. Kurkela, R. Kostiainen, J. Hirvonen, and M. Finel
KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
Drug Metab. Dispos., July 1, 2005; 33(7): 1017 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Elovaara, J. Mikkola, L. Luukkanen, L. Antonio, S. Fournel-Gigleux, B. Burchell, J. Magdalou, and J. Taskinen
ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
Drug Metab. Dispos., December 1, 2004; 32(12): 1426 - 1433.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.